Member access

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Cardiome Pharma Corp.       CA14159U3010

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
05/13/2013 05/14/2013 05/15/2013 05/16/2013 05/17/2013 Date
2.18 2.22 2.16 2.17 2.27 Last
6810 2251 8220 11517 17912 Volume
-1.36% +1.83% -2.70% +0.46% +4.61% Change
Company
Sector
Biotechnology
Calendar
05/22Presentation
Surperformance© rating of Cardiome Pharma Corp.
Trading Rating : - Investor Rating :
More about the company
Chart CARDIOME PHARMA CORP.
Duration : Period :
Cardiome Pharma Corp. Technical Analysis Chart | CA14159U3010 | 4-Traders
Full-screen chart
Financials ( CAD)
Sales 2013 3,78 M
EBIT 2013 -12,4 M
Net income 2013 -6,83 M
Debt 2013 -
Yield 2013 -
Sales 2014 7,07 M
EBIT 2014 -8,43 M
Net income 2014 -2,86 M
Debt 2014 -
Yield 2014 -
PER 2013 11,27
PER 2014
Capi. / Sales 2013 7,56x
Capi. / Sales 2014 4,04x
Capitalization 28,6 M
More Financials
Latest news on CARDIOME PHARMA CORP.
05/09 CARDIOME PHARMA CORP.: Cardiome To Hold First Quarter 2013 Financial Results Co..
05/02 CARDIOME PHARMA CORP.: Cardiome Accepts The Transfer Of Sponsorship Of U.S. And..
04/25 CARDIOME PHARMA CORP.: Cardiome Announces Worldwide Sales And Marketing Of BRIN..
04/02 CARDIOME PHARMA CORP.: Cardiome Appoints Jürgen Polifka, Ph.D., As General Mana..
03/28 CARDIOME PHARMA CORP.: Cardiome Announces The Addition Of Dr. Steen Juul-Möller..
03/15 CARDIOME PHARMA CORP.: Cardiome Reporsts Fourth Quarter And Full Year 2012 Fina..
03/04 CARDIOME PHARMA CORP.: Cardiome Announces Settlement of Debt and Termination of..
02/05 CARDIOME PHARMA CORP.: Cardiome Selects Quintiles To Manage Global Regulatory A..
2012 CARDIOME PHARMA CORP.: Cardiome Reaches Agreement With Merck To Retire Debt And..
2012DJCardiome, Merck Reach Debt Agreement Related to Vernakalant
2012 CARDIOME PHARMA CORP.: Cardiome Reports Third Quarter Results
2012 CARDIOME PHARMA CORP.: NASDAQ Grants Cardiome 180 Day Extension to Regain Compl..
More news
Forum CARDIOME PHARMA CORP.
Advertisement
Income Statement Evolution
Cardiome Pharma Corp. : Income Statement Evolution
More Financials
EPS Revisions
Cardiome Pharma Corp. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.